The study authors are independent from the funders, they had full access to all the data (including statistical reports and tables), they are responsible for the integrity of the data and the accuracy of the data analysis, and they accept responsibility to submit for publication
CPT: Pharmacometrics & Systems Pharmacology, 13(3), 439-451
Weight Regain Reality Data from similar compounds shows that most users regain a portion of lost weight after discontinuation
Noom expands its GLP-1 range with 'microdose' package Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price
Karl Nadolsky, DO, Assistant Clinical Professor at Michigan State University College of Human Medicine and Director of the Endocrine Clinic at the Gym, says there is a paradigm shift toward the quality and kind of weight loss versus a focus on the amount of weight lost
Most stability data supports up to 48 hours at room temperature without significant degradation